Tri-City Cardiology, a Phoenix-based cardiology group among the largest and most respected in the country, has expanded its ...

Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...

Read ahead to know now why the heart beats rapidly all of a sudden for a few seconds what triggers it and when to consult a ...

At the end of the study, the group that drank coffee experienced a 39% lower risk of recurring AFib episodes. In addition to ...

In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...

Edgewise Therapeutics (EWTX) announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical trial of EDG-7500, a novel oral, selective, ...

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

Over 5 million Americans have atrial fibrillation, but many don’t know the red flags.

Objective Patients with atrial fibrillation (AF) frequently have multiple comorbidities that increase the risk of hospitalisation and contribute to higher mortality. However, studies examining the ...

After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.